نتائج البحث - Fabian Gusovsky

  • يعرض 1 - 19 نتائج من 19
تنقيح النتائج
  1. 1
    Regulation of phosphatidylinositol turnover in brain synaptoneurosomes: stimulatory effects of agents that enhance influx of sodium ions.

    Regulation of phosphatidylinositol turnover in brain synaptoneurosomes: stimulatory effects of agents that enhance influx of sodium ions. حسب Fabian Gusovsky, Elizabeth B. Hollingsworth, John W. Daly

    منشور في 1986
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Muscarinic receptor-mediated tyrosine phosphorylation of phospholipase C-gamma. An alternative mechanism for cholinergic-induced phosphoinositide breakdown.

    Muscarinic receptor-mediated tyrosine phosphorylation of phospholipase C-gamma. An alternative mechanism for cholinergic-induced phosphoinositide breakdown. حسب Fabian Gusovsky, John Lueders, Elise C. Kohn, Christian C. Felder

    منشور في 1993
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Cellular Events Mediated by Lipopolysaccharide-stimulated Toll-like Receptor 4

    Cellular Events Mediated by Lipopolysaccharide-stimulated Toll-like Receptor 4 حسب Hua Yang, Donna W. Young, Fabian Gusovsky, Jesse C. Chow

    منشور في 2000
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge

    The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge حسب Patrick Younan, Palaniappan Ramanathan, Jessica Graber, Fabian Gusovsky, Alexander Bukreyev

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction

    Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction حسب Jesse C. Chow, Donna W. Young, Douglas T. Golenbock, William J. Christ, Fabian Gusovsky

    منشور في 1999
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Frog secretions and hunting magic in the upper Amazon: identification of a peptide that interacts with an adenosine receptor.

    Frog secretions and hunting magic in the upper Amazon: identification of a peptide that interacts with an adenosine receptor. حسب John W. Daly, Jorge O. Cáceres, Roger W. Moni, Fabian Gusovsky, Malcolm Moos, Kenneth B. Seamon, Katharine Milton, CE Myers

    منشور في 1992
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    A Novel Synthetic Acyclic Lipid A-like Agonist Activates Cells via the Lipopolysaccharide/Toll-like Receptor 4 Signaling Pathway

    A Novel Synthetic Acyclic Lipid A-like Agonist Activates Cells via the Lipopolysaccharide/Toll-like Receptor 4 Signaling Pathway حسب Egil Lien, Jesse C. Chow, Lynn D. Hawkins, Pamela D. McGuinness, Kensuke Miyake, Terje Espevik, Fabian Gusovsky, Douglas T. Golenbock

    منشور في 2001
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Influenza “Trains” the Host for Enhanced Susceptibility to Secondary Bacterial Infection

    Influenza “Trains” the Host for Enhanced Susceptibility to Secondary Bacterial Infection حسب Kari Ann Shirey, Darren J. Perkins, Wendy Lai, Wei Zhang, Lurds R. Fernando, Fabian Gusovsky, Jorge C. G. Blanco, Stefanie N. Vogel

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection

    A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection حسب Meagan A. Barry, Leroy Versteeg, Qian Wang, Jeroen Pollet, Bin Zhan, Fabian Gusovsky, María Elena Bottazzi, Peter J. Hotez, Kathryn M. Jones

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria

    Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria حسب Bernardo S. Franklin, Sally T. Ishizaka, Marc S. Lamphier, Fabian Gusovsky, Hans Hansen, Jeffrey Rose, Wanjun Zheng, Marco A. Ataide, Rosane B. de Oliveira, Douglas T. Golenbock, Ricardo T. Gazzinelli

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease

    Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease حسب Kathryn M. Jones, Leroy Versteeg, Ashish Damania, Brian Keegan, April Kendricks, Jeroen Pollet, Julio Vladimir Cruz-Chan, Fabian Gusovsky, Peter J. Hotez, María Elena Bottazzi

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease

    Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease حسب Kathryn M. Jones, Elise N. Mangin, Corey L. Reynolds, Liliana E. Villanueva, Julio Vladimir Cruz, Leroy Versteeg, Brian Keegan, April Kendricks, Jeroen Pollet, Fabian Gusovsky, María Elena Bottazzi, Peter J. Hotez

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    A novel antagonist of the prostaglandin E<sub>2</sub> EP<sub>4</sub> receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models

    A novel antagonist of the prostaglandin E<sub>2</sub> EP<sub>4</sub> receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models حسب Q Chen, Kazuyo Muramoto, Nagashima Masaaki, Yinlu Ding, Hua Yang, Megan Mackey, W Li, Yoko Inoue, Karen Ackermann, Hiroshi Shirota, Isao Matsumoto, Mark R. Spyvee, Shawn Schiller, Takayuki Sumida, Fabian Gusovsky, Marc S. Lamphier

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    The TLR4 antagonist Eritoran protects mice from lethal influenza infection

    The TLR4 antagonist Eritoran protects mice from lethal influenza infection حسب Kari Ann Shirey, Wendy Lai, Alison Scott, Michael Lipsky, Pragnesh Mistry, Lioubov M. Pletneva, Christopher L. Karp, Jaclyn W. McAlees, Theresa L. Gioannini, Jerrold Weiss, Wilbur H. Chen, Robert K. Ernst, Daniel P. Rossignol, Fabian Gusovsky, Jorge C. G. Blanco, Stefanie N. Vogel

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Novel strategies for targeting innate immune responses to influenza

    Novel strategies for targeting innate immune responses to influenza حسب Kari Ann Shirey, Wendy Lai, Mira C. Patel, Lioubov M. Pletneva, Catherine J. Pang, Evelyn A. Kurt‐Jones, Michael Lipsky, Thierry Roger, Thierry Calandra, Kevin J. Tracey, Yousef Al‐Abed, Andrew Bowie, Alessio Fasano, Charles A. Dinarello, Fabian Gusovsky, Jorge C. G. Blanco, Stefanie N. Vogel

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial

    Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b... حسب Aditya H. Gaur, James McCarthy, John C. Panetta, Ronald H. Dallas, John Woodford, Li Tang, Amber M. Smith, Tracy B. Stewart, Kristen Branum, Burgess B. Freeman, Nehali Patel, Elizabeth John, Stephan Chalon, Shelley Ost, Ryan N. Heine, Julie Richardson, Robbin Christensen, Patricia M. Flynn, Yvonne Van Gessel, Branko Mitasev, Jörg J. Möhrle, Fabian Gusovsky, Lidiya Bebrevska, R. Kiplin Guy

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    AWZ1066S, a highly specific anti- <i>Wolbachia</i> drug candidate for a short-course treatment of filariasis

    AWZ1066S, a highly specific anti- <i>Wolbachia</i> drug candidate for a short-course treatment of filariasis حسب W. David Hong, Farid Benayoud, Gemma L. Nixon, Louise Ford, Kelly L. Johnston, Rachel H. Clare, Andrew Cassidy, Darren A. N. Cook, Amy Siu, Motohiro Shiotani, Peter J. H. Webborn, Stefan Kavanagh, Ghaith Aljayyoussi, Emma Murphy, Andrew Steven, John Archer, Dominique Struever, Stefan J. Frohberger, Alexandra Ehrens, Marc P. Hübner, Achim Hoerauf, Adam P. Roberts, Alasdair T. M. Hubbard, Edward W. Tate, Remigiusz A. Serwa, Suet C. Leung, Li Qie, Neil G. Berry, Fabian Gusovsky, Janet Hemingway, Joseph D. Turner, Mark J. Taylor, Stephen A. Ward, Paul M. O’Neill

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    The Tuberculosis Drug Accelerator at year 10: what have we learned?

    The Tuberculosis Drug Accelerator at year 10: what have we learned? حسب Bree B. Aldridge, David Barros-Aguirre, Clifton E. Barry, Robert H. Bates, Steven J. Berthel, Helena I. Boshoff, Kelly Chibale, Xin-Jie Chu, Christopher B. Cooper, Véronique Dartois, Ken Duncan, Nader Fotouhi, Fabian Gusovsky, Philip A. Hipskind, Dale J. Kempf, Joël Lelièvre, Anne J. Lenaerts, Case W. McNamara, Valerie Mizrahi, Carl Nathan, David B. Olsen, Tanya Parish, H. Michael Petrassi, Alexander S. Pym, Kyu Y. Rhee, Gregory T. Robertson, Jeremy M. Rock, Eric J. Rubin, Betsy Russell, David G. Russell, James C. Sacchettini, Dirk Schnappinger, Michael R. Schrimpf, Anna M. Upton, Peter Warner, Paul G. Wyatt, Ying Yuan

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Diversity-oriented synthesis yields novel multistage antimalarial inhibitors

    Diversity-oriented synthesis yields novel multistage antimalarial inhibitors حسب Nobutaka Kato, Eamon Comer, Tomoyo Sakata‐Kato, Arvind Sharma, Manmohan Sharma, Micah Maetani, Jessica Bastien, Nicolas M. B. Brancucci, Joshua A. Bittker, Victoria Corey, David C. Clarke, Emily R. Derbyshire, Gillian L. Dornan, Sandra Duffy, Sean Eckley, Maurice A. Itoe, Karin M. J. Koolen, Timothy A. Lewis, Ping S. Lui, Amanda K. Lukens, Emily Lund, Sandra March, Elamaran Meibalan, Bennett C. Meier, Jacob A. McPhail, Branko Mitasev, Eli L. Moss, Morgane Sayes, Yvonne Van Gessel, Mathias J. Wawer, Takashi Yoshinaga, Anne‐Marie Zeeman, Vicky M. Avery, Sangeeta N. Bhatia, John E. Burke, Flaminia Catteruccia, Jon Clardy, Paul A. Clemons, Koen J. Dechering, Jeremy R. Duvall, Michael A. Foley, Fabian Gusovsky, Clemens H. M. Kocken, Matthias Marti, Marshall Morningstar, Benito Muñoz, Daniel E. Neafsey, Amit Sharma, Elizabeth A. Winzeler, Dyann F. Wirth, Christina Scherer, Stuart L. Schreiber

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: